News Focus
News Focus
icon url

linhdtu

08/03/12 1:52 PM

#9524 RE: DewDiligence #9523

Well then with respect to Copax we'll have the same story.

Mnta receives approval for mcopax and ampha or somebody like that will do the same thing ( i am assuming mnta has patented some copax related IPs ).

If this case is dismissed like you say it could be, it is really bad for mnta only because it is small and the business it is in.
icon url

olsen

08/03/12 1:52 PM

#9525 RE: DewDiligence #9523

no protection against mylan on copaxone and the ability of every marginal generic company to say lets let mnta do the work and then we can copy it like amphastar not going to be on the top of many investors top investment pick list?